June 3, 2011 (London, United Kingdom) — Injectable collagenase significantly improved range of motion and degree of contracture in patients with Dupuytren's contracture, compared with placebo, in a ...

February 23, 2011 (San Diego, California) — Collagenase injections are associated with overall satisfactory rates of recontracture in patients with Dupuytren's disease of the hand, according to ...

Because of the increased risk of complications and potential for recurrence associated with invasive surgical techniques, there has been renewed interest in simple fasciotomy to treat flexion ...

Please provide your email address to receive an email when new articles are posted on . Injectable collagenase clostridium histolyticum has revolutionized treatment of Dupuytren’s contracture as the ...

BERLIN — A prospective study of patients with Dupuytren’s contracture whose cords were treated with a collagenase clostridium histolyticum medication approved for use in Europe showed an overall 35% ...

Common activities for patients with Dupuytren's such as those at the workplace (eg, manual labor, wearing gloves) or at home (eg, washing, dressing) can be signicantly affected, posing a threat to ...

Auxilium Pharmaceuticals announced positive top-line data from its open-label phase 3b trial evaluating Xiaflex (collagenase clostridium histolyticum) for the treatment of adult Dupuytren’s ...

Dupuytren’s contracture causes firm, usually painless nodules in the palm to form cords and pull fingers toward the palm over time. It often affects the ring and little fingers, making straightening ...

Auxilium Pharmaceuticals (AUXL) Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p < 0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture XIAFLEX Also Meets ...

K.W. is an active 92-year-old, right-handed, Caucasian female with nodule and contracture formation of the right palmar fascia with extension to the metacarpophalangeal (MCP) and proximal ...